Breast Implants and Reconstructive Devices | Market Insights | US | 2022
The cancellation or postponement of elective procedures, including breast augmentations and reconstructions due to the COVID-19 pandemic had a negative impact on the US market for breast implants and reconstructive devices in 2020. Recovery of the market will be affected by a number of factors, including the pace of vaccine distribution in US, with postpandemic market growth supported by increasing aesthetic consciousness and the overall marketing efforts from the major players.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for breast implants and reconstructive devices in the US across an 11-year period.
